Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Precipio Inc PRPO

Healthcare
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through... see more

Recent & Breaking News (NDAQ:PRPO)

Precipio Releases its 2017 10-K, Files a form S-1, and hosts Fourth Quarter and Full Year Update Call

GlobeNewswire April 17, 2018

Precipio Launches ICE COLD-PCR™ Research Access Program for Cancer Centers

GlobeNewswire April 11, 2018

Important JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core Technology

GlobeNewswire April 3, 2018

Precipio Files Patent for Non-Invasive Cell Capture Device For Gynecological Cancer Detection

GlobeNewswire March 28, 2018

Precipio Enters India Liquid Biopsy Market with Adoption by Leading Laboratory

GlobeNewswire March 26, 2018

Precipio Restructures Capitalization Table

GlobeNewswire March 22, 2018

Precipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy Platform

GlobeNewswire March 20, 2018

Precipio Settles Lawsuit with Crede Capital

GlobeNewswire March 13, 2018

Key Measure of Precipio’s Pathology Sales Growth 4X Prior Quarter

GlobeNewswire February 22, 2018

Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance

GlobeNewswire February 15, 2018

Precipio Announces Q4 2017 Revenue at 350% of Previous Quarter

GlobeNewswire February 9, 2018

Precipio Enters Japanese Liquid Biopsy Market with First Hospital Sale

GlobeNewswire February 6, 2018

Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania

GlobeNewswire January 22, 2018

Precipio Appoints New Sales VP to Manage Diagnostics Sales Expansion

GlobeNewswire January 16, 2018

Yale Study Demonstrates Four-Fold Superiority of Academic Level Diagnostic Accuracy

GlobeNewswire January 10, 2018

Precipio Launches Its Second New ICE-COLD PCR™ Targeted Enrichment Kit To Identify Mutations in Lung Cancer Using Liquid (Blood) Biopsies On Sanger Sequencing Platforms

GlobeNewswire December 20, 2017

OrthoPediatrics Corp. Appoints Samuel D. Riccitelli to its Board of Directors

GlobeNewswire December 15, 2017

Precipio Files a Patent Application for IV-Cell, its Novel Cytogenetics Media

GlobeNewswire December 14, 2017

Precipio, Inc. to Host Earnings Call

Accesswire November 21, 2017

Precipio Announces Third Quarter 2017 Financial Results and Provides Corporate Update

GlobeNewswire November 20, 2017